Clinical Trials Browser

Withdrawn × Cholangiocarcinoma × lenvatinib × Clear all

NCT03801499 2020-05-21

Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma

Phase 2 Withdrawn

Gastrointestinal

Cholangiocarcinoma